Evaluation of the Prevalence of ESBL Multi-Resistant Bacteria, Carbapenemase Producing Enterobacteriaceae in Urinary Tract Infections

1. Bronzwaer S, Lonnroth A, Haigh R. The European Community strategy against antimicrobial resistance. Euro Surveill. 2004; 9: 30-34.10.2807/esm.09.01.00441-en14762318Search in Google Scholar

2. Zhanel GG, DeCorby M, Adam H, Mulvey MR, McCracken M, Lagacé-Wiens P et al. Canadian Antimicrobial Resistance Alliance, Hoban DJ. Prevalence of antimicrobial resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob. Agents. Chemother. 2010; 54(11): 4684-4693.10.1128/AAC.00469-10Search in Google Scholar

3. Hoban DJ, Nicolle LE, Hawser S, Bouchillon S, Badal R. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010 Diagn Microbiol Infect Dis. 2011; 70(4): 507-511.10.1016/j.diagmicrobio.2011.03.021Search in Google Scholar

4. American Journal of Infection Control, Volume 47, Issue 4, April 2019, Pages 371-37510.1016/j.ajic.2018.10.009631263930522837Search in Google Scholar

5. Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and Management of Pediatric Urinary Tract Infections Clinical microbiology reviews. 2005, 18(2): 417-422.10.1128/CMR.18.2.417-422.2005Search in Google Scholar

6. Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin Infect Dis. 2004;39:1835_41.10.1086/42574415578408Search in Google Scholar

7. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K,Betlejewska K, Hryniewicz W (2001) Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 47:773–78010.1093/jac/47.6.77311389109Search in Google Scholar

7. Magill SS, Edwards JR, Bamberg W, Beldaus ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson D, Wilson LE, Fridkin SK: Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014, 370:1198–1208.10.1056/NEJMoa1306801464834324670166Search in Google Scholar

8. Paterson DL, Bonomo RA. 2005. Extended-spectrum-lactamases: aclinical update. Clin. Microbiol. Rev. 18:657–686.10.1128/CMR.18.4.657-686.2005126590816223952Search in Google Scholar

9. World Health Organization. Antimicrobial resistance. Geneva: WHO; 2014Search in Google Scholar